NASDAQ:GNOM Global X Genomics & Biotechnology ETF - GNOM Stock Forecast, Price & News Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Global X Genomics & Biotechnology ETF Please log in to your account or sign up in order to add this asset to your watchlist. $13.83 +0.12 (+0.88%) (As of 01/27/2023 12:00 AM ET) Add Share Share Today's Range$13.63▼$13.8950-Day Range$12.11▼$13.8352-Week Range$10.48▼$17.02Volume64,314 shsAverage Volume69,001 shsMarket Capitalization$230.96 millionP/E RatioN/ADividend Yield0.00%Price TargetN/A ProfileChartFinancialsInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial Media About Global X Genomics & Biotechnology ETF (NASDAQ:GNOM) StockComplete Genomics, Inc. is a life sciences company that has developed and commercialized a deoxyribonucleic acid (DNA) sequencing platform. Its complete genomics analysis platform (CGA) Platform, combines its human genome sequencing technology with its advanced informatics and data management software and its end-to-end, outsourced service model to provide its customers with data that is ready to be used for genome-based research. Its genome sequencing center combines a high-throughput sample preparation facility, a collection of its high-throughput sequencing instruments and a large- scale data center. Its customers include some of the global academic and government research centers and biopharmaceutical companies. Effective March 18, 2013, BGI-Shenzhen announced that through its wholly-owned subsidiary, Beta Acquisition Corporation, it has completed the acquisition of the Company.Read More Receive GNOM Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Global X Genomics & Biotechnology ETF and its competitors with MarketBeat's FREE daily newsletter. Email Address GNOM Stock News HeadlinesJanuary 23, 2023 | americanbankingnews.comGlobal X Genomics & Biotechnology ETF (NASDAQ:GNOM) Short Interest Down 15.1% in DecemberJanuary 18, 2023 | seekingalpha.comGNOM: Get Exposure To The Latest Genomics And Biotechnology CompaniesJanuary 28, 2023 | Porter & Company (Ad)Is This The End of Capitalism?EXPOSED: The establishment plot to disenfranchise and impoverish millions of Americans…January 18, 2023 | americanbankingnews.comGlobal X Genomics & Biotechnology ETF (NASDAQ:GNOM) Share Price Crosses Above Two Hundred Day Moving Average of $13.45January 10, 2023 | markets.businessinsider.comComplete Genomics Launches Full Sequencing Platforms at Biotech Showcase™ 2023January 6, 2023 | benzinga.comGlobal X Adaptive U.S. Risk Management ETF (ONOF): November ReportOctober 12, 2022 | seekingalpha.com10x Genomics: No Signs Of A Growth Turnaround, Heavy Bearish MomentumJuly 15, 2022 | benzinga.comWhat 5 Analyst Ratings Have To Say About 10x GenomicsJanuary 28, 2023 | Porter & Company (Ad)Is This The End of Capitalism?EXPOSED: The establishment plot to disenfranchise and impoverish millions of Americans…June 16, 2022 | benzinga.comNIH's National Human Genome Research Institute and NSTA Unveil New Genome: Unlocking Life's Code Educational Resources for EducatorsJune 6, 2022 | markets.businessinsider.comUltima Genomics Collaborates with NVIDIA To Deliver $100 Genome Sequencing with AI and Accelerated ComputingDecember 29, 2021 | msn.comIs ARK's Stellar Run Over? 5 ETF Themes to Follow Cathie WoodDecember 22, 2021 | nasdaq.comGet Exposure to Global X Thematic ETFs in This One FundJuly 16, 2021 | nasdaq.comSnag Next-Generation Tech Exposure with This Genomics ETFJune 4, 2021 | msn.comETF Battles: ARKG vs. GNOM - Which Is The Better Genomics/Biotech Play?December 29, 2020 | msn.comTop-Performing Biotech ETFs Amid the COVID-19 CrisisDecember 24, 2020 | msn.com4 Best Sector ETFs of Q4December 23, 2020 | nasdaq.comGet On Board a Growing Biotech Industry With the GNOM ETFNovember 26, 2020 | barrons.comGlobal X Genomics & Biotechnology ETFNovember 25, 2020 | finance.yahoo.comETF Wrap: A very ETF Thanksgiving, and tax season tooOctober 18, 2020 | nasdaq.comGlobal X Genomics & Biotechnology ETF (GNOM)October 15, 2020 | msn.comWhy You Should Invest in Genomics ETFsJune 18, 2020 | www.nasdaq.comBiotechnology Is Hot, But It's Getting Scorching in This SegmentMay 26, 2020 | www.msn.com3 Genomics ETFs Worth Jumping ForMay 26, 2020 | finance.yahoo.comGenomics ETF (GNOM) Hits New 52-Week HighMarch 28, 2020 | markets.businessinsider.comThe single cell sequencing industry analysis projects the market to grow at a significant CAGR of 15.24% during the forecast period, 2019-2029March 20, 2020 | www.marketwatch.comMicro Electro Mechanical Systems Market Emerging Opportunities, Growing Demand and Significant Trends by 2027See More Headlines View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart Receive GNOM Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Global X Genomics & Biotechnology ETF and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeNASDAQ Industry N/A Sub-IndustryN/A SectorN/A Current SymbolNASDAQ:GNOM CUSIPN/A CIK1361103 Webwww.completegenomics.com Phone+1-650-9432800FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding Shares16,700,000Free FloatN/AMarket Cap$230.96 million OptionableNot Optionable BetaN/A Insiders & InstitutionsClearwater Capital Advisors LLCBought 15,239 shares on 1/27/2023Ownership: 0.091%Sightline Wealth Advisors LLCBought 18,912 shares on 1/26/2023Ownership: 0.441%Elmwood Wealth Management Inc.Sold 800 shares on 1/26/2023Ownership: 0.367%Archford Capital Strategies LLCSold 3,095 shares on 1/26/2023Ownership: 0.119%Halbert Hargrove Global Advisors LLCSold 1,724 shares on 1/25/2023Ownership: 0.073%View All Institutional Transactions GNOM Stock - Frequently Asked Questions How have GNOM shares performed in 2023? Global X Genomics & Biotechnology ETF's stock was trading at $12.65 at the beginning of the year. Since then, GNOM stock has increased by 9.3% and is now trading at $13.8298. View the best growth stocks for 2023 here. Are investors shorting Global X Genomics & Biotechnology ETF? Global X Genomics & Biotechnology ETF saw a increase in short interest in the month of January. As of January 15th, there was short interest totaling 130,200 shares, an increase of 45.0% from the December 31st total of 89,800 shares. Based on an average trading volume of 101,000 shares, the days-to-cover ratio is currently 1.3 days. View Global X Genomics & Biotechnology ETF's Short Interest. What other stocks do shareholders of Global X Genomics & Biotechnology ETF own? Based on aggregate information from My MarketBeat watchlists, some companies that other Global X Genomics & Biotechnology ETF investors own include Inovio Pharmaceuticals (INO), Gilead Sciences (GILD), Intel (INTC), Pfizer (PFE), Quest Diagnostics (DGX), Micron Technology (MU), Dynavax Technologies (DVAX), Matinas BioPharma (MTNB). What is Global X Genomics & Biotechnology ETF's stock symbol? Global X Genomics & Biotechnology ETF trades on the NASDAQ under the ticker symbol "GNOM." Who are Global X Genomics & Biotechnology ETF's major shareholders? Global X Genomics & Biotechnology ETF's stock is owned by a number of institutional and retail investors. Top institutional investors include Private Advisor Group LLC (6.47%), McGuire Investment Group LLC (1.50%), Sightline Wealth Advisors LLC (0.44%), Elmwood Wealth Management Inc. (0.37%), Archford Capital Strategies LLC (0.12%) and Clearwater Capital Advisors LLC (0.09%). How do I buy shares of Global X Genomics & Biotechnology ETF? Shares of GNOM stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is Global X Genomics & Biotechnology ETF's stock price today? One share of GNOM stock can currently be purchased for approximately $13.83. How much money does Global X Genomics & Biotechnology ETF make? Global X Genomics & Biotechnology ETF (NASDAQ:GNOM) has a market capitalization of $230.96 million. How can I contact Global X Genomics & Biotechnology ETF? Global X Genomics & Biotechnology ETF's mailing address is 2071 Stierlin Ct, MOUNTAIN VIEW, CA 94043-4655, United States. The official website for the company is www.completegenomics.com. The company can be reached via phone at +1-650-9432800. This page (NASDAQ:GNOM) was last updated on 1/28/2023 by MarketBeat.com Staff Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.